← Leaderboards
Nancy Ratner
Cincinnati Childrens Hosp Med Ctr
$25,011,276
Attributed
$31,254,692
Total exposure
17
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$38,083,523 · 18
By mechanism
R01$23,735,902 · 8
P50$8,187,767 · 3
R37$2,744,100 · 1
P30$1,416,666 · 1
R33$788,678 · 1
R21$772,910 · 1
Top collaborators
- David Andrew Largaespada10 shared
- Jack Hoopes5 shared
- Itamar Kahn5 shared
- Yolanda Sanchez5 shared
- Jianqiang Wu3 shared
- Timothy P Cripe2 shared
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Itamar Kahn$1,123,307
- George Thomas$3,140,507
Others in their field
Top investigators on “Schwann Cells”
- Jeffrey D Milbrandt · Washington University$13,457,530
- James L Salzer · New York University School Of Medicine$12,321,534
- David W. Clapp · Indiana University Indianapolis$10,172,902
- Susan E Mackinnon · Washington University$9,862,202
- John P Svaren · University Of Wisconsin Madison$8,821,814
- Maria L Feltri · Istituto Scientifico San Raffaele$8,539,546
Research focus
Schwann CellsMouse ModelTumorCellsNeurofibromaNeurofibromatosis 1In VivoIn VitroPathway InteractionsAffectMutationNf1 GeneBenignNeoplastic CellNeurofibromatosesSignal TransductionNerveLoss Of FunctionTumorigenesisGenesGeneticMolecularBaseMutant
Grant awards (93)
Identification of Germline Modifiers of Neurofibromatosis Type 1 Tumors$597,778
R01 · FY2025 · NS · contact PI
Mitogenic Activities in Neurofibromatosis$546,646
R01 · FY2025 · NS · contact PI
Identification of Novel Pathways Causing NF1-Driven Schwann Cell Tumors$500,637
R01 · FY2025 · NS · contact PI
Identification of germline modifiers of Neurofibromatosis type 1 tumors$656,513
R01 · FY2024 · NS · contact PI
Mitogenic Activities in Neurofibromatosis$589,163
R01 · FY2024 · NS · contact PI
Uncovering treatment targets for peripheral nerve sheath tumor progression in NF1$548,991
R01 · FY2024 · NS
Identification of Novel Pathways Causing NF1-Driven Schwann Cell Tumors$485,617
R01 · FY2024 · NS · contact PI
Mitogenic Activities in Neurofibromatosis$74,119
R01 · FY2024 · NS · contact PI
Mitogenic Activities in Neurofibromatosis$607,383
R01 · FY2023 · NS · contact PI
Uncovering treatment targets for peripheral nerve sheath tumor progression in NF1$571,785
R01 · FY2023 · NS
Identification of novel pathways causing NF1-driven Schwann cell tumors$500,637
R01 · FY2023 · NS · contact PI
Uncovering treatment targets for peripheral nerve sheath tumor progression in NF1$577,428
R01 · FY2022 · NS
Identification of novel pathways causing NF1-driven Schwann cell tumors$500,637
R01 · FY2022 · NS · contact PI
Targeting Complement 5a-Mediated Immunoregulation for Neurofibroma Therapy$391,227
R33 · FY2022 · NS
Uncovering treatment targets for peripheral nerve sheath tumor progression in NF1$582,915
R01 · FY2021 · NS
Mitogenic Activities in Neurofibromatosis$445,976
R01 · FY2021 · NS · contact PI
Targeting Complement 5a-Mediated Immunoregulation for Neurofibroma Therapy$397,451
R33 · FY2021 · NS
Uncovering treatment targets for peripheral nerve sheath tumor progression in NF1$587,214
R01 · FY2020 · NS
Mitogenic Activities in Neurofibromatosis$445,976
R01 · FY2020 · NS · contact PI
Ras Proteins in Nerve Tumorigensis$397,500
R37 · FY2020 · NS · contact PI
Targeting Tumors with NF1 Loss$531,751
R01 · FY2019 · NS
Mitogenic Activities in Neurofibromatosis$445,976
R01 · FY2019 · NS · contact PI
Ras Proteins in Nerve Tumorigensis$397,500
R37 · FY2019 · NS · contact PI
Targeting complement 5a-mediated immunoregulation for neurofibroma therapy$397,500
R61 · FY2019 · NS
Brain Dysfunction in Neurofibromatosis$309,792
R01 · FY2019 · NS · contact PI
Targeting Tumors with NF1 Loss$541,146
R01 · FY2018 · NS
Disordered Regulation of Wnt/beta-catenin Signaling in MPNST Development and Maintenance$496,936
R01 · FY2018 · NS
Mitogenic Activities in Neurofibromatosis$445,976
R01 · FY2018 · NS · contact PI
Ras Proteins in Nerve Tumorigensis$397,500
R37 · FY2018 · NS · contact PI
Brain Dysfunction in Neurofibromatosis$309,792
R01 · FY2018 · NS · contact PI
Targeting Tumors with NF1 Loss$544,581
R01 · FY2017 · NS
Disordered Regulation of Wnt/beta-catenin Signaling in MPNST Development and Maintenance$491,889
R01 · FY2017 · NS
Mitogenic Activities in Neurofibromatosis$416,302
R01 · FY2017 · NS · contact PI
Ras Proteins in Nerve Tumorigensis$390,000
R37 · FY2017 · NS · contact PI
Brain Dysfunction in Neurofibromatosis$309,792
R01 · FY2017 · NS · contact PI
Targeting Tumors with NF1 Loss$547,736
R01 · FY2016 · NS
Disordered Regulation of Wnt/beta-catenin Signaling in MPNST Development and Maintenance$486,944
R01 · FY2016 · NS
Ras Proteins in Nerve Tumorigensis$390,000
R37 · FY2016 · NS · contact PI
Brain Dysfunction in Neurofibromatosis$309,792
R01 · FY2016 · NS · contact PI
Targeting Tumors with NF1 Loss$572,285
R01 · FY2015 · NS
Disordered Regulation of Wnt/beta-catenin Signaling in MPNST Development and Maintenance$482,094
R01 · FY2015 · NS
Ras Proteins in Nerve Tumorigensis$390,000
R37 · FY2015 · NS · contact PI
Novel Combinatorial Therapies for Malignant Peripheral Nerve Sheath Tumors$379,455
R21 · FY2015 · NS · contact PI
Mitogenic Activities in Neurofibromatosis$353,813
R01 · FY2015 · NS · contact PI
Brain Dysfunction in Neurofibromatosis$322,042
R01 · FY2015 · NS · contact PI
Disordered Regulation of Wnt/beta-catenin Signaling in MPNST Development and Maintenance$490,339
R01 · FY2014 · NS
Novel Combinatorial Therapies for Malignant Peripheral Nerve Sheath Tumors$393,455
R21 · FY2014 · NS · contact PI
Ras Proteins in Nerve Tumorigensis$381,600
R37 · FY2014 · NS · contact PI
Mitogenic Activities in Neurofibromatosis$350,274
R01 · FY2014 · NS · contact PI
Mitogenic Activities in Neurofibromatosis$341,429
R01 · FY2013 · NS · contact PI
Cincinnati Center of Neurofibromatosis Research$1,290,446
P50 · FY2012 · NS · contact PI
Mitogenic Activities in Neurofibromatosis$353,813
R01 · FY2012 · NS · contact PI
Ras Proteins in NF1$292,295
P50 · FY2012 · NS · contact PI
Administration Core$59,775
P50 · FY2012 · NS · contact PI
Cincinnati Center of Neurofibromatosis Research$1,393,352
P50 · FY2011 · NS · contact PI
Mitogenic Activities in Neurofibromatosis$353,813
R01 · FY2011 · NS · contact PI
Ras Proteins in NF1$315,970
P50 · FY2011 · NS · contact PI
Schwann Cells in Neurofibromatosis Type 2 (NF2)$276,450
R01 · FY2011 · CA · contact PI
Administration Core$64,616
P50 · FY2011 · NS · contact PI
2011 Neurofibromatosis (NF) Conference$40,000
R13 · FY2011 · NS · contact PI
Cincinnati Center of Neurofibromatosis Research$1,287,589
P50 · FY2010 · NS · contact PI
Cincinnati Neuro-Oncology Research Core$710,000
P30 · FY2010 · CA · contact PI
Mitogenic Activities in Neurofibromatosis$425,581
R01 · FY2010 · NS · contact PI
Schwann Cells in Neurofibromatosis Type 2 (NF2)$285,000
R01 · FY2010 · CA · contact PI
Ras Proteins in NF1$182,634
P50 · FY2010 · NS · contact PI
Cincinnati Center of Neurofibromatosis Research$104,057
P50 · FY2010 · NS · contact PI
Administration Core$37,275
P50 · FY2010 · NS · contact PI
Cincinnati Center of Neurofibromatosis Research$1,286,182
P50 · FY2009 · NS · contact PI
Cincinnati Neuro-Oncology Research Core$706,666
P30 · FY2009 · CA · contact PI
Mitogenic Activities in Neurofibromatosis$417,364
R01 · FY2009 · NS · contact PI
Schwann Cells in Neurofibromatosis Type 2 (NF2)$285,000
R01 · FY2009 · CA · contact PI
Cincinnati Center of Neurofibromatosis Research$197,229
P50 · FY2009 · NS · contact PI
Ras Proteins in NF1$169,116
P50 · FY2009 · NS · contact PI
Mitogenic Activities in Neurofibromatosis$80,750
R01 · FY2009 · NS · contact PI
Administration Core$34,531
P50 · FY2009 · NS · contact PI
Cincinnati Center of Neurofibromatosis Research$1,269,976
P50 · FY2008 · NS · contact PI
Mitogenic Activities in Neurofibromatosis$324,008
R01 · FY2008 · NS · contact PI
Schwann Cells in Neurofibromatosis Type 2 (NF2)$285,000
R01 · FY2008 · CA · contact PI
Ras Proteins in NF1$168,335
P50 · FY2008 · NS · contact PI
Administration Core$34,389
P50 · FY2008 · NS · contact PI
Mitogenic Activities in Neurofibromatosis$393,401
R01 · FY2007 · NS · contact PI
Schwann Cells in Neurofibromatosis Type 2 (NF2)$285,000
R01 · FY2007 · CA · contact PI
Mitogenic Activities in Neurofibromatosis$25,000
R01 · FY2007 · NS · contact PI
Mitogenic Activities in Neurofibromatosis$413,041
R01 · FY2006 · NS · contact PI
MITOGENIC ACTIVITIES IN NEUROFIBROMATOSIS$216,488
R01 · FY2004 · NS
MITOGENIC ACTIVITIES IN NEUROFIBROMATOSIS$117,790
R01 · FY2004 · NS
MITOGENIC ACTIVITIES IN NEUROFIBROMATOSIS$340,288
R01 · FY2003 · NS
MITOGENIC ACTIVITIES IN NEUROFIBROMATOSIS$340,477
R01 · FY2002 · NS
MITOGENIC ACTIVITIES IN NEUROFIBROMATOSIS$333,078
R01 · FY2001 · NS
Mitogenic activities in neurofibromatosis$0
M01 · FY2001 · RR
MITOGENIC ACTIVITIES IN NEUROFIBROMATOSIS$234,464
R01 · FY2000 · NS
MITOGENIC ACTIVITIES IN NEUROFIBROMATOSIS$30,000
R01 · FY2000 · NS
Mitogenic activities in neurofibromatosis$0
M01 · FY2000 · RR